Axsome Therapeutics Inc AXSM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:10 PM EDT
73.25quote price arrow up+0.17 (+0.23%)
Volume
10,806
Close
73.08quote price arrow up+1.98 (+2.78%)
Volume
692,131
52 week range
55.02 - 98.40
Loading...
  • Open71.53
  • Day High74.34
  • Day Low70.30
  • Prev Close71.10
  • 52 Week High98.40
  • 52 Week High Date02/12/24
  • 52 Week Low55.02
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap3.462B
  • Shares Out47.37M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change-8.18

KEY STATS

  • Open71.53
  • Day High74.34
  • Day Low70.30
  • Prev Close71.10
  • 52 Week High98.40
  • 52 Week High Date02/12/24
  • 52 Week Low55.02
  • 52 Week Low Date11/13/23
  • Market Cap3.462B
  • Shares Out47.37M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change-8.18

RATIOS/PROFITABILITY

  • EPS (TTM)-5.20
  • P/E (TTM)-14.06
  • Fwd P/E (NTM)-20.57
  • EBITDA (TTM)-224.991M
  • ROE (TTM)-159.21%
  • Revenue (TTM)270.60M
  • Gross Margin (TTM)90.37%
  • Net Margin (TTM)-88.41%
  • Debt To Equity (MRQ)93.24%

EVENTS

  • Earnings Date05/06/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Axsome Therapeutics Inc

 

Profile

MORE
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in developing and delivering therapies for central nervous system (CNS), conditions that have limited treatment options. The Company's two commercial products and development programs are Auvelity and Sunosi. Auvelity (dextromethorphan-bupropion) is an oral, N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity indicated for the treatment of major depressive...
Herriot Tabuteau M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Mark Jacobson
Chief Operating Officer
Nick Pizzie CPA
Chief Financial Officer
Lori Englebert
Executive Vice President - Commercial and Business Development
Hunter Murdock Esq.
General Counsel
Address
One World Trade Center, 22Nd Floor
New York, NY
10007
United States

Top Peers

SYMBOLLASTCHG%CHG
INSM
Insmed Inc
25.27+1.16+4.81%
IMCR
Immunocore Holdings PLC
57.31+1.49+2.67%
MOR
MorphoSys AG
18.04+0.08+0.45%
FOLD
Amicus Therapeutics Inc
10.71-0.11-1.02%
ARWR
Arrowhead Pharmaceuticals Inc
23.78-0.14-0.59%